- Home
- EM vs LRMR Comparison
EM vs LRMR Comparison
Compare EM & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EM
- LRMR
- Stock Information
- Founded
- EM 2017
- LRMR N/A
- Country
- EM China
- LRMR United States
- Employees
- EM N/A
- LRMR N/A
- Industry
- EM Other Consumer Services
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- EM Consumer Discretionary
- LRMR Health Care
- Exchange
- EM Nasdaq
- LRMR Nasdaq
- Market Cap
- EM 286.5M
- LRMR 309.8M
- IPO Year
- EM 2021
- LRMR N/A
- Fundamental
- Price
- EM $1.35
- LRMR $4.08
- Analyst Decision
- EM Hold
- LRMR Strong Buy
- Analyst Count
- EM 1
- LRMR 7
- Target Price
- EM $1.25
- LRMR $18.43
- AVG Volume (30 Days)
- EM 1.6M
- LRMR 1.3M
- Earning Date
- EM 11-26-2025
- LRMR 10-29-2025
- Dividend Yield
- EM N/A
- LRMR N/A
- EPS Growth
- EM N/A
- LRMR N/A
- EPS
- EM N/A
- LRMR N/A
- Revenue
- EM $259,541,587.00
- LRMR N/A
- Revenue This Year
- EM $3.30
- LRMR N/A
- Revenue Next Year
- EM $5.26
- LRMR N/A
- P/E Ratio
- EM N/A
- LRMR N/A
- Revenue Growth
- EM N/A
- LRMR N/A
- 52 Week Low
- EM $0.50
- LRMR $1.61
- 52 Week High
- EM $1.45
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- EM 63.13
- LRMR 57.29
- Support Level
- EM $1.34
- LRMR $3.84
- Resistance Level
- EM $1.37
- LRMR $4.26
- Average True Range (ATR)
- EM 0.03
- LRMR 0.28
- MACD
- EM -0.00
- LRMR 0.00
- Stochastic Oscillator
- EM 63.64
- LRMR 71.10
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.